Serum 5-Hydroxytryptamine is Related to Psoriasis Severity in Patients with Comorbid Anxiety or Depression

Serum 5-Hydroxytryptamine is Related to Psoriasis Severity in Patients with Comorbid Anxiety or Depression

Bibliographic Details
Main Authors:	Minxue Shen, Duling Cao, Yi Xiao, Yehong Kuang, Danrong Jing, Yajia Li, Panpan Liu, Xiang Chen, Wu Zhu
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2021-08-01
Series:	Acta Dermato-Venereologica
Subjects:	psoriasis serum serotonin anxiety depression effect modification
Online Access:	https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3857

Similar Items

Association of Psoriasis With Anxiety and Depression: A Case–Control Study in Chinese Patients
by: Danrong Jing, et al.
Published: (2021-12-01)

Association of Serum Vitamin D With Psoriasis and Effect Modification by Central Obesity
by: Yehong Kuang, et al.
Published: (2020-06-01)

Anxiety and depressive symptoms in patients with psoriasis
by: R. Sallemi, et al.
Published: (2021-04-01)

Evaluation of Depression and Anxiety Disorders and Correlation with the Treatment of Patients with Psoriasis Vulgaris
by: Adriana Kamilly Leitão Pitman Machado, et al.
Published: (2020-12-01)

Evaluation of anxiety sensitivity in patients with psoriasis
by: Hilal Kaya Erdogan, et al.
Published: (2019-01-01)

A cross-sectional study of prevalence and implications of depression and anxiety in psoriasis
by: Sreelatha Lakshmy, et al.
Published: (2015-01-01)

The estimation of 5-hydroxytryptamine (serotonin) in biological tissues /
by: 432134 Udenfriend, Sidney, et al.

Epidemiology of mental health comorbidity in psoriasis
by: J. J. Wu, et al.
Published: (2018-07-01)

Beneath the Skin: The Relationship Between Psychological Distress and the Immune System in Patients with Psoriasis
by: Mahmoud Elsayed, et al.
Published: (2018-10-01)

Association of the attachment styles with depression, anxiety, and quality of life in patients with psoriasis
by: Onur Okan Demirci, et al.
Published: (2020-01-01)

Persistent Depressive Disorder: the Clinical Approach of the Patient Associating Depression and Dental Pathology - Case Report and Clinical Considerations
by: Marius MOROIANU, et al.
Published: (2022-03-01)

Assessment of anxiety, depression, social anxiety, anxiety sensitivity, and perceived stress in psoriasis patients: a controlled cross-sectional study
by: Taha Can Tuman, et al.
Published: (2021-11-01)

Depression and anxiety among patients with psoriasis: A correlation with quality of life and associated factors
by: Raishan S. Bakar, DrPH, et al.
Published: (2021-08-01)

Biologic Therapies Decrease Disease Severity and Improve Depression and Anxiety Symptoms in Psoriasis Patients
by: Teodora-Larisa Timis, et al.
Published: (2023-05-01)

Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis
by: Alejandro Molina-Leyva, et al.
Published: (2015-06-01)

On the guestion of comorbidity in psoriasis
by: Bakulev A.L., et al.
Published: (2014-09-01)

Predicting the Risk of Psoriatic Arthritis in Plaque Psoriasis Patients: Development and Assessment of a New Predictive Nomogram
by: Panpan Liu, et al.
Published: (2022-01-01)

Patients with Moderate to Severe Psoriasis Associate with Higher Risk of Depression and Anxiety Symptoms: Results of a Multivariate Study of 300 Spanish Individuals with Psoriasis
by: Maria José Tribó, et al.
Published: (2019-01-01)

Studies on the 5-hydroxytryptamine (serotonin) content in human brain /
by: 443349 Costa, E., et al.

A Study of Serum Uric Acid Level in Patients with Psoriasis at a Tertiary Care Hospital in Eastern Nepal
by: Manish Pradhan, et al.
Published: (2022-06-01)

Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study
by: Marina Talamonti, et al.
Published: (2021-03-01)

Oxidative stress and inflammatory response in patients with psoriasis; is there any relationship with psychiatric comorbidity and cognitive functions?
by: Erdem Deveci, et al.
Published: (2019-10-01)

Postnatal Treadmill Exercise Alleviates Prenatal Stress-Induced Anxiety in Offspring Rats by Enhancing Cell Proliferation Through 5-Hydroxytryptamine 1A Receptor Activation
by: Sam Jun Lee, et al.
Published: (2016-05-01)

Psoriasis and Comorbidities
by: Arzu Kılıç, et al.
Published: (2013-12-01)

Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysi
by: Isabelle Jalenques, et al.
Published: (2022-08-01)

Coptisine Alleviates Imiquimod-Induced Psoriasis-like Skin Lesions and Anxiety-like Behavior in Mice
by: Ly Thi Huong Nguyen, et al.
Published: (2022-02-01)

Pediatric patients with psoriasis and psychiatric disorders: premorbidity and comorbidity in a case-control study
by: Tayfun Kara, et al.
Published: (2019-02-01)

TRACE ELEMENTS HOMEOSTATIC IMBALANCE IN MILD AND SEVERE PSORIASIS: A NEW INSIGHT IN BIOMARKER DIAGNOSTIC VALUE FOR PSORIASIS
by: Nagat Sobhy Mohamad
Published: (2013-10-01)

Clinical Study of Serum Serotonin as a Screening Marker for Anxiety and Depression in Patients with Type 2 Diabetes
by: Lavinia-Alexandra Moroianu, et al.
Published: (2022-05-01)

Skin tissue expression and serum level of thymic stromal lymphopoietin in patients with psoriasis vulgaris
by: Oki Suwarsa, et al.
Published: (2019-06-01)

The Mechanism of Secretion and Metabolism of Gut-Derived 5-Hydroxytryptamine
by: Ning Liu, et al.
Published: (2021-07-01)

Evaluation Of Neopterin Level And Disease Severity In Patients With Psoriasis Vulgaris Treated With Narrowband UVB
by: Eisa Mohamed Hegazy, et al.
Published: (2023-07-01)

Assessment of efficacy and safety of UV-based therapy for psoriasis: a network meta-analysis of randomized controlled trials
by: Yajia Li, et al.
Published: (2022-12-01)

The Analysis of Serum Vitamin D (25[OH]D) Level in Psoriasis Patients Comparing with Control Subjects
by: Ade Fernandes, et al.
Published: (2020-07-01)

Correlation between trough serum levels of adalimumab and absolute PASI score in a series of patients with psoriasis
by: J. M. Carrascosa, et al.
Published: (2018-02-01)

Low Vitamin D in psoriasis: Reality or myth?
by: Preethi B Nayak, et al.
Published: (2018-01-01)

Serum Adenosine Deaminase Activity in Monitoring Disease Activity and Response to Therapy in Severe Psoriasis
by: Zülal Erbagci, et al.
Published: (2006-01-01)

Total Serum IgE Concentration in Patients with Psoriasis: a Case-Control Study
by: Vahideh Lajevardi, et al.
Published: (2014-07-01)

The Brain–Skin Connection and the Pathogenesis of Psoriasis: A Review with a Focus on the Serotonergic System
by: Ana M. Martins, et al.
Published: (2020-03-01)

The occurrence of anxiety, depression, and suicidal thoughts in patients with psoriasis
by: Magdalena Stachecka, et al.
Published: (2019-12-01)